Table 2.
Co-morbidities and demographics.
| Control Group | Platelet Plasma Group | |
|---|---|---|
| Sex | ||
| Male | 47 | 46 |
| Female | 3 | 4 |
| Type of procedure—endograft | ||
| AAA aorto-mono-iliac EndoFit + fem-fem bypass | 8 | 16 |
| AAA Endologix | 2 | 5 |
| AAA straight EndoFit | 3 | 7 |
| AAA Talent | 34 | 6 |
| AAA Anaconda | 2 | 10 |
| AAA Gore Excluder | 1 | 6 |
| Total | 50 | 50 |
| Number of common femoral arteries that were surgically exposed | 98 | 95 |
| Co-morbidities | ||
| Arterial hypertension | 28 | 21 |
| Current smoking habit or quit smoking ≤12 months ago (≥10 pack-years) | 24 | 29 |
| Current smoking habit or quit smoking <12 months ago (≥10 pack-years) | 2 | 6 |
| Ex-smoker = quit smoking ≥12 months ago | 8 | 1 |
| Chronic renal insufficiency | 0 | 2 |
| Hostile abdomen | 0 | 1 |
| Chronic obstructive pulmonary disease | 5 | 3 |
| Previous stroke | 3 | 1 |
| Diabetes mellitus | 5 | 4 |
| Coronary artery disease | 23 | 19 |
| Previous acute myocardial infarction | 11 | 12 |
| Hyperlipidemia at admission (total serum cholesterol ≥240 mg/dL and serum LDL ≥130 mg/dL) | 23 | 27 |